
Aerospace and defense company Rocket Lab (NASDAQ:RKLB) beat Wall Street’s revenue expectations in Q3 2026, with sales up 72.7% year on year to $267.8 million. On top of that, next quarter’s revenue guidance ($280 million at the midpoint) was surprisingly good and 5.1% above what analysts were expecting. Its non-GAAP loss of $0 per share was $0.01 above analysts’ consensus estimates.
Is now the time to buy RKLB? Find out in our full research report (it’s free for active Edge members).
Rocket Lab's latest quarter saw robust revenue growth and a surge in contract backlog, but the market responded negatively due to profitability concerns. Management credited the strong sales performance to exceptional demand for both its launch services and space systems segments, highlighting new multi-launch contracts with commercial and government customers. CEO Peter Beck noted, “Demand for launch has been exceptional this year,” with major contract wins for Electron, HASTE, and Neutron vehicles. However, management acknowledged that higher operating expenses and integration costs from recent acquisitions weighed on margins, resulting in greater-than-expected losses.
Looking ahead, Rocket Lab’s guidance is underpinned by expectations of continued strong launch demand and the scaling of its space systems business, despite ongoing investment in Neutron development. Management anticipates sequential revenue growth driven by new launches and contributions from recent acquisitions, while also projecting margin improvement as production efficiencies are realized. CFO Adam Spice cautioned that elevated R&D and capital spending will persist, stating, “Cash consumption will remain elevated due to Neutron development and scaling production.” The company is focused on accelerating Neutron’s launch cadence and integrating Iridium, which executives believe will diversify the business and support future cash generation.
Management attributed the quarter’s performance to surging demand in both launch services and space systems, alongside strategic acquisitions and production scaling. Margin pressures stemmed from Neutron development and integration costs.
Management’s outlook centers on maintaining high launch cadence, scaling space systems, and integrating Iridium to drive margin expansion and cash flow improvement.
In upcoming quarters, the StockStory team will monitor (1) Neutron’s development milestones, particularly progress toward first flight and ramping production, (2) the pace of Electron and HASTE launch activity as a sign of sustained demand and pricing power, and (3) the closing and integration of the Iridium acquisition, especially its impact on recurring revenue and cash flow. We will also track the ability to manage R&D and capital spending as Neutron scales and to secure additional space systems contracts.
Rocket Lab currently trades at $54.97, down from $58.67 just before the earnings. Is there an opportunity in the stock? See for yourself in our full research report (it’s free).
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.